Based on the information available, there are no specific vaccine precautions explicitly stated for Cosentyx (secukinumab) users. However, it is generally recommended that individuals on biologic therapies, such as Cosentyx, maintain up-to-date vaccinations before starting treatment [1].

Cosentyx is a biologic medication used to treat various conditions, including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. Biologic therapies like Cosentyx work by targeting specific parts of the immune system, which may affect vaccine efficacy and immune response [2].

The Centers for Disease Control and Prevention (CDC) recommends that adults on biologic therapies follow the standard immunization schedule [3]. However, some live vaccines might be contraindicated or require additional consideration [3]. Therefore, it is essential to consult with a healthcare provider to discuss vaccination plans and potential interactions with Cosentyx [1].

In summary, while there are no specific vaccine precautions for Cosentyx users, maintaining up-to-date vaccinations and discussing vaccine plans with a healthcare provider is recommended for individuals on biologic therapies [1][2][3].

Sources:
[1] Cosentyx (secukinumab) [Prescribing Information]. (2021). Novartis Pharmaceuticals Corporation. Retrieved from <https://www.novartis.us/sites/www.novartis.us/files/cosentyx.pdf>
[2] Vaccines and Immunizations for Persons with Chronic Disabilities. (2021). Centers for Disease Control and Prevention. Retrieved from <https://www.cdc.gov/vaccines/adults/rec-vac/chronically-ill.html>
[3] Recommended Adult Immunization Schedule by Age Group. (2021). Centers for Disease Control and Prevention. Retrieved from <https://www.cdc.gov/vaccines/schedules/hcp/imz/adult.html>

(Note: DrugPatentWatch.com was not used as a source for this response)